# Ziprasidone and Sertraline in PTSD

> **NCT00248261** · — · TERMINATED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 7 (actual)

## Conditions studied

- Post-traumatic Stress Disorder

## Interventions

- **DRUG:** ziprasidone, sertraline

## Key facts

- **NCT ID:** NCT00248261
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2009-08
- **Final completion:** 2010-06
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** High rate of early drop-outs
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00248261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00248261, "Ziprasidone and Sertraline in PTSD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00248261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*